Home
February 2010 March 2010 April 2010
Su Mo Tu We Th Fr Sa
Week 9 1 2 3 4 5 6
Week 10 7 8 9 10 11 12 13
Week 11 14 15 16 17 18 19 20
Week 12 21 22 23 24 25 26 27
Week 13 28 29 30 31
Reach urologists

Overactive Bladder
UroToday's Overactive Bladder section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of overactive bladder. Also available are conference coverage for all timely overactive bladder science, audio podcasts and downloadable slides from UroToday's slide library.
Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.
Kind regards,
Christian Gratzke, MD
Associate Section Editor Overactive Bladder
UroToday International Journal

Search    Display results per page
Results 466 - 480 of 758
<< Start < Prev 31 32 33 34 35 36 37 38 39 40 Next > End >>
UroToday International Journal Publishes the First Issue; a Supplement of Abstracts from the ICI July 2008 Meeting in Paris, France
Wednesday, 25 June 2008
BERKELEY, CA, USA (Press Release) - June 25, 2008
read more

Therapeutic Satisfaction and Dissatisfaction in Patients with Spinal Cord Lesions and Detrusor Sphincter Dyssynergia Who Received Detrusor Botulinum Toxin A Injection - Abstract
Friday, 20 June 2008
Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan.
read more

Bilateral Single-system Ureteroceles With Multiple Calculi in an Adult Woman - Abstract
Friday, 20 June 2008
Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
read more

A Letter to U.S. Physicians About Intermittent Urinary Catheterization
Friday, 20 June 2008
read more

Urgency in Overactive Bladder: Translating Experimental Data into Clinical Practice - Abstract
Wednesday, 18 June 2008
Urology, Faculty of Medicine and University Hospital Antwerp, University Antwerp, Belgium.
read more

Clinical Female Sexual Outcome After Sacral Neuromodulation Implant for Lower Urinary Tract Symptom (LUTS) - Abstract
Wednesday, 18 June 2008
Urology, S. Maria Annunziata Hospital, University of Florence, Florence, Italy.
read more

Refractory Idiopathic Urge Urinary Incontinence and Botulinum A Injection - Abstract
Friday, 13 June 2008
Departments of Obstetrics and Gynecology and Urology, Loyola University Medical Center (LB), Maywood, Illinois.
read more

Treatment with Propiverine in Children Suffering from Nonneurogenic Overactive Bladder and Urinary Incontinence: Results of a Randomized Placebo-Controlled Phase 3 Clinical Trial - Abstract
Wednesday, 11 June 2008
Frankfurt/Main, Germany.
read more

Human Urine with Solifenacin Intake but not Tolterodine or Darifenacin Intake Blocks Detrusor Overactivity - Abstract
Friday, 06 June 2008
Department of Urology, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University College of Medicine, 123, Ta-Pei Road, Niao-Song Hsiang, Kaohsiung Hsien, Taiwan.
read more

Roles of Mechanosensitive Ion Channels in Bladder Sensory Transduction and Overactive Bladder - Abstract
Wednesday, 04 June 2008
Department of Urology, University of Yamanashi Interdisciplinary Graduate School of Medicine and Engineering, Chuo, Japan.
read more

Relationships Between Improvements in Symptoms and Patient Assessments of Bladder Condition, Symptom Bother and Health-Related Quality of Life in Patients with Overactive Bladder Treated with Tolterodine - Abstract
Wednesday, 04 June 2008
Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA.
read more

Positional Changes in Voiding Dynamics of Children with Non-Neurogenic Bladder Dysfunction - Abstract
Wednesday, 04 June 2008
Department of Urology, Gaziosmanpasa University School of Medicine, Merkez/Tokat, Turkey.
read more

AUA 2008 - Urodynamics/Incontinence/Female Urology: Incontinence: Evaluation and Therapy (III) MP#58
Monday, 02 June 2008
ORLANDO, FL (UroToday.com) - Dr. Daniel Schmid presented long-term follow up from Zurich, Switzerland on 200 non-neurogenic overacvtive bladder patients received low-dose (100 units) of botulinum toxin A (BoNT-A) detrusor injections (Abstract #1658).
Login to read more...

AUA 2008 - Prevalence of Genital Mycoplasma Infection and Treatment Efficacy in Women with Overactive Bladder Symptoms
Monday, 02 June 2008
ORLANDO, FL (UroToday.com) - Dr. Hye Won Lee and colleagues from Seoul, Korea presented their work examining 84 women with overactive bladder symptoms persisting for greater than 3 months.
Login to read more...

AUA 2008 - Urodynamics/Incontinence/Female Urology: Female Urology (I) – MP#49
Monday, 02 June 2008
ORLANDO, FL (UroToday.com) - The potential role of stem cells in the treatment of incontinence and pelvic prolapse has been a subject of much attention.
Login to read more...




Promoting World Continence




Focus on Overactive Bladder

Focus on Overactive Bladder condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.





Podcast - Effective Darifenacin Treatment after Dissatisfaction with Prior Extended-Release Antimuscarinic Therapy






Differential Pharmacological Effects of Antimuscarinic Drugs on Heart Rate: A Randomized, Placebo-Controlled, Double-Blind, Crossover Study with Tolterodine and Darifenacin in Healthy Participants > or = 50 years

- by Brian Olshansky, MD

Darifenacin Treatment for Overactive Bladder in Patients Who Expressed Dissatisfaction With Prior Extended-Release Antimuscarinic Therapy

- by Norman Zinner, MD, et al.

Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment

- by Alexander Roosen, MD and Clare J. Fowler, MD

A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder

- by Giacomo Novara, MD, FEBU

Emerging Drugs for Treatment of Overactive Bladder and Detrusor Overactivity

- by Marcus Drake, MD



Two Types of Urgency

- by Philip M. Hanno, MD, MPH - Editor's Pick

Long-Term Efficacy and Safety of Tolterodine in Children with Neurogenic Detrusor Overactivity

- by Pasquale Casale, MD

Defining Overactive Bladder as Hypersensitivity

- by Philip M. Hanno, MD, MPH



Minimally Invasive Therapy for Neurogenic Detrusor Overactivity: A Review

- by Karl-Erik Andersson, Roger Dmochowski and Alan Wein

A Randomized Controlled Study of Posterior Tibial Nerve Stimulation for Overactive Bladder

- by Paula Palma, MD, PhD. et al.

Efficacy and Tolerability of Add-On Trospium Chloride in Patients with Benign Prostate Syndrome and Overactive Bladder: A Noninterventional Trial Showing Use of Flexible Dosing

- by Ulrich Schwantes, PhD, et al.






The second-line management of idiopathic overactive bladder: What is the place of sacral neuromodulation and botulinum toxin-A in contemporary practice?



On the Origins of the Sensory Output from the Bladder: The Concept of Afferent Noise




A Review of Adherence to Drug Therapy in Patients with Overactive Bladder



Sacral Neuromodulation for Treating the Symptoms of Overactive Bladder Syndrome and Non-Obstructive Urinary Retention: More Than 10 Years of Clinical Experience




Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study

- by Michael Chancellor, MD, et al.

Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release

- by Michael G. Oefelein, MD, et al.

Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical observations and research discovery

- by Michael Chancellor, MD.

The evolution of transdermal therapy for overactive bladder

- by Peter K. Sand, MD

Outcome of a Randomized, Double-Blind, Placebo Controlled Trial of Botulinum A Toxin for Refractory Overactive Bladder

- by Michael K. Flynn, MD, et al.

InterStim Therapy: A Contemporary Approach to Overactive Bladder

- by Neeraj Kohli, MD, MBA and Danielle Patterson, MD

Differential Pharmacological Effects of Antimuscarinic Drugs on Heart Rate: A Randomized, Placebo-Controlled, Double-Blind, Crossover Study with Tolterodine and Darifenacin in Healthy Participants > or = 50 years

- by Brian Olshansky, MD, et al.

Randomized Comparison of Tolterodine With Vaginal Estrogen Cream Versus Tolterodine Alone for the Treatment of Postmenopausal Women With Overactive Bladder Syndrome

- by Ling-Hong Tseng, MD, et al.









The role of industry funding in randomized controlled trials of antimuscarinic medications for overactive bladder

- Session Highlight by Ariana L. Smith, MD from the International Continence Society (ICS) 39th Annual Meeting

State of the Art Lecture: Bladder re-innervation: Can new nerves improve the function of the neurogenic bladder?

- Session Highlight by Ariana L. Smith, MD from the International Continence Society (ICS) 39th Annual Meeting

Is ultrasound bladder wall thickness a better measure than urodynamics for overactive bladder symptoms?

- Session Highlight by Ariana L. Smith, MD from the International Continence Society (ICS) 39th Annual Meeting

Urodynamics/Incontinence/Female Urology: Urodynamic Testing - Identification of Measures of Bladder Sensation in Patients with Overactive Bladder

- Session Highlight by Kathleen Kobashi, MD from the 2009 Annual Meeting of the American Urological Association (AUA)

Session Highlights from the Society for Urodynamics & Female Urology 2009 Winter Meeting

- Exclusive Coverage by UroToday Contributing Medical Editor, William Jaffe, MD

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at The National Institutes of Health (NIH) - UI Symposium

- Session Highlights Reported by Diane K. Newman

Drug Treatment - Lecture Series


- Presented by Karl-Erik Andersson, MD, PhD, and Christopher Chapple, MD, et al. at the Fourth International Consultation on Incontinence (ICI)


Drug Treatment - Committee Meeting Highlights


- Reported by William Jaffe, MD from the Fourth International Consultation on Incontinence (ICI)

Voiding Dysfunction Session Highlights


- From the American Urological Association 2008 Annual Meeting

Urodynamics and Reality


- Presented by Ed McGuire, MD, at the 32nd Winter Urologic Forum

Clinical Proof of Concept Study (BLOSSOM) Shows Novel Beta 3 Adrenoceptor Agonist YM178 is Effective and Well Tolerated in the Treatment of Symptoms of Overactive Bladder

- Presented at the European Association of Urology - 23rd Annual EAU Congress

International Consultation on Incontinence - ICI 2008

- Session Abstracts, Overactive Bladder
 
<< Start < Prev 31 32 33 34 35 36 37 38 39 40 Next > End >>
Results 466 - 480 of 758
back

UroToday, 1802 Fifth Street, Berkeley CA 94710
510.540.0930 (fax), info@urotoday.com
ISSN 1939-4810
UroToday International Journal Correspondence
About The Editors | About Us | Contact Us | Report an Inaccuracy | Sponsorship Opportunities | Terms of Use


Privacy Policy | © 2010 UroToday ® All Rights Reserved

Member's Section

Login

Sign Up

Quick Search


Advanced Search

Meet the Expert


All Experts



Featured Conference

Media and Publisher

Advertising Rates

Working with Industry

Case Studies
Sponsorship Opportunities

Overactive Bladder
Sponsored By